These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Endothelin-1 activates the R-type Ca2+ channel in vascular smooth-muscle cells.
    Author: Bkaily G, Naik R, D'Orléans-Juste P, Wang S, Fong CN.
    Journal: J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S303-6. PubMed ID: 8587396.
    Abstract:
    Endothelin-1 (ET-1) induced a concentration-dependent sustained increase of intracellular calcium ([Ca2+]i) in single cells of rabbit aortic vascular smooth-muscle cells (VSMCs). This sustained [Ca2+]i increase was insensitive to the L-type Ca2+ antagonist nifedipine but was sensitive to isradipine and the presence of extracellular Ca2+. The ET(A) receptor antagonist BQ-123, ET-3, and the selective ETB agonist BQ-3020 had no effect on ET-1-induced sustained [Ca2+]i increase. Pretreatment with caffeine or ryanodine did not prevent the effect of ET-1 on [Ca2+]i. However, ET-1 did not induce further increases in the sustained [Ca2+]i increase induced by either high levels of extracellular potassium [K]0 or insulin, nor did ET-1 have any effect on potassium or L-type calcium channels. Our results suggest that the sustained [Ca2+]i increase induced by ET-1, as with insulin, was mainly due to activation of a nifedipine-insensitive but isradipine-sensitive steady-state, voltage-dependent R-type calcium channel via an as yet unidentified ET receptor.
    [Abstract] [Full Text] [Related] [New Search]